DRW Securities LLC Makes New $5.99 Million Investment in iShares Biotechnology ETF (NASDAQ:IBB)

DRW Securities LLC acquired a new position in iShares Biotechnology ETF (NASDAQ:IBB) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 41,139 shares of the financial services provider’s stock, valued at approximately $5,990,000.

Several other large investors have also recently bought and sold shares of the business. Blue Fin Capital Inc. raised its position in iShares Biotechnology ETF by 0.7% in the second quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock worth $1,443,000 after acquiring an additional 74 shares in the last quarter. Security National Bank of SO Dak increased its position in shares of iShares Biotechnology ETF by 0.7% in the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after buying an additional 75 shares in the last quarter. SPC Financial Inc. increased its position in shares of iShares Biotechnology ETF by 2.4% in the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after buying an additional 75 shares in the last quarter. Werba Rubin Papier Wealth Management increased its position in shares of iShares Biotechnology ETF by 2.7% in the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after buying an additional 76 shares in the last quarter. Finally, Main Street Financial Solutions LLC increased its position in iShares Biotechnology ETF by 1.0% during the 2nd quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock worth $1,098,000 after purchasing an additional 82 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB stock opened at $137.96 on Monday. The firm has a 50-day moving average price of $143.43 and a 200 day moving average price of $141.87. iShares Biotechnology ETF has a twelve month low of $117.28 and a twelve month high of $150.57.

iShares Biotechnology ETF Announces Dividend

The company also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.